{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-132481","form_type":"8-K","ticker":"TVRD","cik":"0001346830","company_name":"Tvardi Therapeutics, Inc.","filed_at":"2024-12-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.229431+00:00","generated_at":"2026-05-28T22:40:10.221822+00:00","sec_items":["5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Cara Therapeutics effects 1-for-12 reverse stock split and reduces authorized shares from 200M to ~16.7M","bullets":["Effective 5:00 p.m. ET Dec 30, 2024; trading on split-adjusted basis begins Dec 31, 2024.","Authorized common shares reduced from 200,000,000 to 16,666,667; par value unchanged.","No fractional shares issued; cash payment will be made in lieu of fractional shares.","Proportionate adjustments made to stock options, equity plan reserves, and exercise prices.","Stockholder-approved at June 4, 2024 annual meeting; board approved specific ratio Dec 19, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-132481","json":"https://secwatch.observer/filing/0001104659-24-132481.json","markdown":"https://secwatch.observer/filing/0001104659-24-132481.md","text":"https://secwatch.observer/filing/0001104659-24-132481.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1346830/000110465924132481/0001104659-24-132481-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1346830/000110465924132481/tm2430195d4_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T22:40:10.221822+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}